Medtronic MDT came up with a mixed performance for the third quarter of fiscal 2025, sparking investor concerns and a ...

Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...

Medtronic Plc (NYSE:MDT) reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion. The ...

Medtronic (NYSE: MDT) recently announced its Q3 fiscal 2025 results (fiscal ends in April), reporting revenue of $8.29 billion, slightly below the $8.33 billion consensus estimate. Adjusted ...

Medtronic Plc. shares slumped nearly 7.3% on Tuesday — their worst single-day decline since March 2020 — after the company's ...

Medtronic (MDT) stock slips as the company reaffirms full-year outlook after delivering mixed financial for Q3 fiscal 2025.

Our Q3 revenue of $8.3 billion grew 4.1% organic ... and I look forward to your continued contributions to Medtronic. Now, Terry will be joining us in a couple of weeks. And as I've heard from ...

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...

Medtronic saw $8.3 billion in revenue during the third quarter of fiscal year 2025, according to financial results posted Feb. 18.

Medtronic Q3 revenue of $8.29 billion missed estimates, but EPS of $1.39 beat the $1.36 consensus. Medtronic reaffirms FY25 organic growth guidance of 4.75%-5%. Get ...